Cardiovascular disease is the leading cause of death in men and women from most ethnic
groups in the US. In response to the growing number of people suffering from cardiovascular disease, many people are unaware that there is ample evidence demonstrating that chelation therapy is an extremely safe, effective and nontoxic treatment in reversing and preventing various cardiovascular conditions. Since 1952, EDTA chelation therapy has been used to treat atherosclerosis in the U.S. but
has also been used to treat lead poisoning and heavy metal toxicity.
Chelation therapy is largely credited to a German chemist named F. Munz. He was a pioneer in synthesizing EDTA (ethylenediaminetetraacetic acid). It was patented in German in 1930 and first used medically in 1941 for lead poisoning. It was then patented in the US in 1949, with numerous published papers in the 1950’s outlining its therapeutic effects. It was noted that during its use for heavy metal chelation, many patients reported a reduction in symptoms from angina (chest pain). There have been numerous papers written to support the therapeutic improvements to cardiovascular health through chelation therapy. In the last 50 years, there have been thousands of scientific articles written discerning the various aspects of EDTA chelation therapies, as well as its safety and efficacy. These theories have been proven by its use on hundreds of thousands of patients in well over three million separate intravenous treatments by over 1000 doctors over the last fifty years.
EDTA has multiple mechanisms of actions, one being that it can positively affect arterial plaque formation and build up, as well as cell membrane function. Other studies have shown EDTA’s ability to effectively fight free radical scavengers, which can be very important in maintaining coronary and vascular health. Another important reason that EDTA is well indicated for coronary and vascular disease is that EDTA is a calcium channel blockers. These medicines curb the flow of calcium and other minerals in your blood and blood vessels to reduce spasms, irregular heartbeats and ultimately relieving chest pain. EDTA differs from most other calcium channel blockers because not only does it relieve the calcification of the arteries but spasming of the arteries as well.
Chelation therapy is widely ignored and condemned by conventional Medicine. It has been denounced by the American Medical Association and the American Heart Association due to its threat to the current establishment system. Chelation therapy would undermine current surgical and pharmacological treatment protocols. Additionally, EDTA chelation has now “lost” its patent rights from 1949 and no pharmaceutical company wants to undertake the huge sums of money required to adequately document the therapeutic effects of chelation therapy for purposes of being recognized by the FDA.
- https://www.acc.org/latest-in-cardiology/articles/2016/02/26/09/34/chelation-therapy for-cad
- Hawken, C.M., Chelation Therapy: An Effective Method for Maintaining Cardiovascular Health. Jan. 1997